Kaplan-Meier analysis of OS not censored for transplant in RATIFY showed a 22% reduction in risk of death with midostaurin plus chemotherapy vs placebo + chemotherapy.^aCox model stratified on FLT3 subtype; 1-sided, log-rank P value. Adapted from Stone et al¹⁰  with permission. CI, confidence interval; NR, not reached.